Cite
HARVARD Citation
Hu, C. et al. (2020). CUDC‐907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action. Journal of cellular and molecular medicine. 24 (13), pp. 7239-7253. [Online].